AltruBio

Our Commitment

Throughout the clinical trials process, the patient is our highest priority. We are committed to improving access to and participation in clinical trials by using insights from the patient community in trial designs, exploring novel technology-enabled solutions and implementing strategies to ensure that our trials reflect the diversity of patients. Compliance with this standard provides the public assurance that the rights, safety and well-being of trial subjects are protected, a practice that is consistent with global ethical standards and regulatory requirements. We recognize that the results of clinical trials should advance public health. Thus, we commit to providing access to the trial information and outcomes, whether positive or negative, to the patient community and others.